Ustekinumab induces rapid clearing of erythrodermic psoriasis after failure of antitumour necrosis factor therapies

被引：37

作者：

Santos-Juanes, J. ^{[1
]}

Coto-Segura, P. ^{[1
]}

Mas-Vidal, A. ^{[1
]}

Osuna, C. Galache ^{[2
]}

机构：

[1] Hosp Univ Cent Asturias, Fac Med, Serv Dermatol 2, Oviedo 33006, Spain

[2] Hosp Cabuenes, Dermatol Sect, Gijon, Spain

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2010年 / 162卷 / 05期

关键词：

arthritis; psoriasis; ustekinumab; INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; TRIAL; EFFICACY; SAFETY;

D O I：

10.1111/j.1365-2133.2010.09669.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1144 / 1146

页数：3

共 4 条

[1] Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial [J].

Gottlieb, Alice ;

Menter, Alan ;

Mendelsohn, Alan ;

Shen, Yaung-Kaung ;

Li, Shu ;

Guzzo, Cynthia ;

Fretzin, Scott ;

Kunynetz, Rod ;

Kavanaugh, Arthur .

LANCET, 2009, 373 (9664) :633-640

[2]

Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4

[3] Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) [J].

Papp, Kim A. ;

Langley, Richard G. ;

Lebwohl, Mark ;

Krueger, Gerald G. ;

Szapary, Philippe ;

Yeilding, Newman ;

Guzzo, Cynthia ;

Hsu, Ming-Chun ;

Wang, Yuhua ;

Li, Shu ;

Dooley, Lisa T. ;

Reich, Kristian .

LANCET, 2008, 371 (9625) :1675-1684

[4]

PINK AE, 2010, BR J DERMATOL

← 1 →